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Introduction
In patients with polycystic ovary syndrome (PCOS), endogenous insulin levels are increased due to insulin resistance [1] . Hyperinsulinemia reinforces local insulin-like growth factor (IGF)-I activity in the ovary and, as a result, this induces an androgenic composition in theca cells [2] . Both increased IGF-I activity and a high androgenic environment appear to be involved in the ovulation disorder in PCOS patients [3] .
The growing and maturating process of ovarian follicles occurs as a consequence of functional interactions between gonadotropins and various autocrine/paracrine factors in the ovary. It has been shown that the ovarian bone morphogenetic protein (BMP) system plays a critical role in the regulation of follicular steroidogenesis in an autocrine/paracrine manner [4, 5] . BMPs exert a common biological activity to suppress progesterone synthesis stimulated by follicle-stimulating hormone (FSH) as a luteinizing inhibitor. In growing follicles, exquisite control of FSH responsiveness is necessary for the Hasegawa, Otsuka et al. -5 -physiological selection of dominant follicles and the successive ovulation.
BMPs are key regulatory molecules for the maintenance of FSH activity as well as FSH sensitivity during the process of normal folliculogenesis [4, 6] .
The BMP system molecules including BMP ligands and the receptors exhibit a cell-specific expression pattern in ovarian follicles. Among these, the expression of BMP-6 is localized in oocytes and granulosa cells at Graafian stages of rat healthy follicles [6] . BMP-6 has an inhibitory effect on FSH receptor actions by suppressing adenylate cyclase, leading to cAMP reduction, in rat granulosa cells [7, 8] . BMP-6 expressed in rat granulosa cells appears to be reduced at the step of selecting dominant follicles [6] , suggesting that BMP-6 physiologically conduces to the selection process.
From the standpoint of the pathophysiology of human PCOS, examination of ovary tissues revealed that growth and differentiation factor (GDF)-9 mRNA expression, compared to BMP-15, was delayed and decreased in growing follicles from PCOS ovaries [9] . Moreover, it is of note that the expression of BMP-6 is highly increased in human granulosa cells isolated from Hasegawa, Otsuka et al. -6 -PCOS ovaries [10, 11] .
In the present study, we investigated the functional roles of androgen and IGF-I in ovarian steroidogenesis by focusing on BMP-6, which suppresses progesterone biosynthesis, using primary culture of rat granulosa cells. It was clarified that androgen excess and IGF-I action interact mutually and accelerate steroidogenesis by regulating endogenous BMP signaling in rat granulosa cells.
Hasegawa, Otsuka et al. the oocyte/granulosa cell suspension through 100-and 40-μm nylon meshes (BD Falcon, Bedford, MA) that allowed granulosa cells but not oocytes to pass through [12, 13] . The isolated granulosa cells were then cultured in a serum-free McCoy's 5A medium supplemented with penicillin-streptomycin at 37C in an atmosphere of 5% CO2. The animal protocols were approved by Okayama University Institutional Animal Care and Use Committee.
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Materials and Methods
Reagents and supplies
Determination of estradiol, progesterone and cAMP levels
Rat granulosa cells (1 × 10 5 viable cells in 200 μl) were cultured, as described 
Western immunoblotting analysis
Rat granulosa cells (2.5 × 10 5 viable cells in 500 l) were cultured in 24 
Results
We first investigated the combined effects of androgen and IGF-I on regulation of ovarian steroidogenesis using rat primary granulosa cells isolated from immature female rat ovaries. In order to exclude the effect of conversion of testosterone to estradiol [16] , we utilized DHT, instead of testosterone, as an androgen for assessment of the appropriate AR action.
As shown in Fig. 1 , individual treatment with IGF-I (100 ng/ml) or DHT (100 nM) did not affect basal levels of estradiol ( Fig. 1A) and progesterone ( Fig.   1B ) production by rat granulosa cells for 48-h culture. Treatment with IGF-I (0 to 300 ng/ml) increased FSH (10 ng/ml)-induced estradiol production ( Fig. 1A) as well as progesterone production ( Fig. 1B) by granulosa cells in a concentration-responsive manner. Treatment with DHT (100 nM) only marginally increased estradiol production in the presence of FSH plus IGF-I (0 to 300 ng/ml) ( Fig. 1A) . On the other hand, it was of note that DHT (100 nM) treatment significantly enhanced FSH-induced progesterone production in the Hasegawa, Otsuka et al.
- 14 - presence of IGF-I (0 to 300 ng/ml) ( Fig. 1B) .
To confirm the effects of androgen and IGF-I on steroidogenesis, we examined the mRNA levels of steroidogenic enzymes including StAR, P450scc, 3HSD and P450arom by quantitative real-time PCR. We previously reported that treatment with IGF-I enhances FSH-induced expression of StAR, P450scc, 3βHSD and P450arom in rat granulosa cells [17] . In the present study, we focused on the effects of androgen on steroidogenic enzyme expression induced by FSH and IGF-I. As shown in Fig. 2 , co-treatment with DHT (100 nM) further enhanced the effects of IGF-I (100 ng/ml) on expression of StAR, P450scc and 3HSD mRNAs induced by FSH (10 ng/ml) in rat granulosa cells for 48 h ( Fig.   2A ). On the other hand, in accordance with the results for estradiol production ( Fig. 1A) , the mRNA levels of P450arom were not significantly altered under the condition of the same treatment with DHT and IGF-I ( Fig. 2A) .
To determine the mechanism by which androgen and IGF-I regulate for 48-h culture (Fig. 2B) , being in accordance with the changes in progesterone production induced by DHT (Fig. 1B) . To determine the mutual interaction between the effects of androgen and IGF-I in granulosa cells, the expression levels of IGF-IR and AR were examined by quantitative PCR. As shown in The expression level of another type-II receptor, BMPRII, was not significantly changed by DHT treatment, although the effect was different from that induced by IGF-I. We also assessed changes in the expression of inhibitory Smads including Smad6 and Smad7. As shown in Fig. 3C , the expression levels of Smad6 and Smad7 mRNA were significantly increased by IGF-I (100 ng/ml) and
DHT (100 nM), respectively, in rat granulosa cells for 48 h.
Discussion
In the present study, we hypothesized that a high androgenic environment and increased IGF-I activity are mutually involved in the dysregulation of steroidogenesis in PCOS, leading to ovulation disorders. By using rat primary granulosa cell culture, it was revealed that the combined effect of androgen and IGF-I promoted FSH-induced progesterone production, compared with estradiol production, by suppressing endogenous BMP signaling (Fig. 4) .
The ovarian IGF-I system plays key roles in normal folliculogenesis and also in the degenerative process of follicular atresia [18, 19] , in which IGF-I is involved in the enhancement of FSH sensitivity by upregulating FSH receptor (FSHR) expression on granulosa cells. The significance of IGF-I activity in the development of PCOS pathology and enhanced IGF-IR expression during early preantral development has been reported [2] . On the other hand, roles of androgen and its receptor AR in the pathophysiology of PCOS have also been recognized [20] . AR is expressed in oocytes, granulosa cells and theca cells of -18 -preantral follicles in the rat ovary, in which the expression pattern of AR is different depending on the development stage of follicles [20] . In the present study, it was found that IGF-I treatment upregulated the expression of AR mRNA, while androgen treatment in turn suppressed the expression of IGF-IR mRNA in rat granulosa cells. An androgen excess is clinically related to insulin resistance and/or metabolic syndrome in women [21] . In rodents, long-term treatment with DHT has been demonstrated to cause various reproductive and metabolic features of PCOS. For instance, DHT-treated rodents exhibited reduced ovulation with polycystic changes of the ovaries encompassing atretic follicles, thickened theca and thinned granulosa cells [22] [23] [24] , suggesting a direct effect of AR actions on the development of reproductive and metabolic features of PCOS but with species-dependent differences.
Relationships between androgen and ovarian growth factors have been
reported for IGFs and transforming growth factor (TGF)  superfamily members.
In addition to the synergistic effects of androgen and FSH, androgen enhances the proliferation of granulosa cells induced by IGF-I alone or GDF-9 in the Hasegawa, Otsuka et al.
- 19 - presence of IGF-I [25, 26] . Direct AR effects also enhance the differentiation of rat granulosa cells, with testosterone acting via the AR to increase the expression of P450arom and P450scc [27] . The expression levels of factors for the oocyte-granulosa cell regulatory loop, such as Kit ligand, BMP-15 and GDF-9, are reduced in AR-deficient mouse ovaries at the preovulatory stage [28] .
Pathophysiological involvement of BMP system molecules in PCOS has also been reported [9, 29, 30] . Of interest, female GDF-9-knockout mice showed PCO-like morphological features of the ovaries containing ovarian follicular cysts lined by several layers of flattened granulosa cells [31] . Examination of ovarian tissues derived from PCOS patients clarified that GDF-9 expression was significantly delayed and weakened during the differentiation phase [9] .
Therefore, it is presumed that ovarian growth factors such as GDFs and BMPs are directly linked to the functional and morphological changes shown in PCOS.
We previously reported that the ovarian growth hormone (GH)/IGF-I system acts to modulate steroidogenesis in rat granulosa cells [17] . IGF-I impaired BMP-Smad1/5/8 signaling via downregulation of the expression of Clinical investigations have shown that the expression of BMP-6 mRNA was significantly increased in human granulosa cells isolated from PCOS patients in comparison with that in granulosa cells from control patients who underwent in vitro fertilization [10, 11] . Since BMP-6 expression is abundant in granulosa cells of healthy growing follicles but not in atretic follicles in the human ovary [32] , the overexpression of BMP-6 in granuslosa cells may indicate the Collectively, the results indicate that androgen enhances IGF-I-induced progesterone production by counteracting endogenous BMP-6 actions in granulosa cells (Fig. 4) , which might be functionally linked to the altered steroidogenic property shown in the PCOS ovary. In this regard, we earlier reported the activity of melatonin, which has been shown to be effective for the infertility of PCOS [33] , on ovarian steroidogenesis [34] . In that study, it was found that melatonin plays an antagonistic role in BMP-6 actions in rat granulosa cells. Since BMP-6 has the property of a luteinization inhibitor in growing follicles, the results indicated that melatonin maintains progesterone synthesis and luteinization by inhibiting BMP-6 activity in rat granulosa cells. Such inhibitory effects of melatonin or androgen on BMP-6 activity could be effective for compensating the impaired progesterone production and the arrest of it is suggested that balanced intensities between androgen/IGF-I and the BMP system are physiologically critical for fine-tuning ovarian steroidogenesis in growing follicles (Fig. 4) . 
